In a continuous effort to search for bioactive agents from medicinal plants, the antidiarrhoea activity of I. asarifolia was investigated. The effect of hydromethanolic leave extract of I. asarifolia (HLEIA) on castor oil-induced diarrhoea, gastrointestinal transit and intestinal fluid accumulation (enteropooling) were assessed in albino rats. Qualitative phytochemical analysis was carried out using standard procedures while acute oral toxicity studies was determined using the staircase method.
INTRODUCTION
The use of plants for medicinal purposes is an age old tradition in Africa, Asia and Latin America [1, 2] . Medicinal plants are plants containing inherent active ingredients used to cure disease or relieve pain [3] . The striking coincidence between indigenous medicinal plants uses and scientifically-proved phytochemical and pharmacological properties shows that the traditional remedies are an important and effective part of indigenous healthcare systems which is totally dependent on traditional healers [4] . Growing interest on the use of medicinal plants for primary health care is greatly influenced by the rising cost and side effects associated with most modern drugs. Modern pharmacopoeia still contains at least 25% of drugs derived from plants and many others, which are synthetic analogues, built on prototype compounds isolated from plants [5] .
Ipomoea asarifolia (Convolvulaceae) is a glabrous succulent perennial plant trailing on the ground. It is found throughout West Africa and is a common weed of hydromorphic soils, low lying and inland valleys, streams and river banks. In Nigeria, the traditional names include "Duman kada" in Hausa and "Gboro ayaba" in Yoruba [6] . Various parts of the plant are used by traditional medicine practitioners in Nigeria for the management and treatment of several disorders which include opthalmia, neuralgia, headache, arthritic pains and stomach ache. In Kebbi (North-West Nigeria), Ipomea asarifolia has been widely used for the treatment of various stomach disorders including diarrhoea.
Diarrhoea is a leading cause of malnutrition and globally, there are nearly 1.7 billion cases of childhood diarrhoeal disease every year [7] . It is a very common ailment and national problem in many tropical countries and the cause of 4-5 million deaths throughout the world annually [8] . Diarrhoea remains the second leading cause of death among children under five globally [9] .
Nigeria was estimated to have a total number of annual child deaths due to diarrhoea to be 151,700 [9] . Diarrhoea may be caused by a wide array of agents such as entero-pathogenic microorganisms (Shigella flexneri and Shigella dysenteriae, Staphylococcus aureus, Escherichia coli, Salmonella typhi and Candida albicans), alcohol, irritable bowel syndrome, bile salts, hormones, secretory tumors and intoxication [10, 11] . Dependency on plants as medicine in controlling diseases is common among rural populace in Nigeria because of its relative safety and affordability compared with the cost of conventional medicines. Therefore, there is need to provide scientific bases of justification on the therapeutic uses of medicinal plants against infectious diseases. Ipomea asarifolia has been used in traditional medicine for treating various ailments, including diarrheal, without scientific verification of its effects. The present study was therefore designed to validate this claim of Ipomea asarifolia in the treatment of diarrhoea by the communities in Kebbi State, Northwest Nigeria.
MATERIALS AND METHODS

Plant Collection
The fresh leaves of Ipomea asarifolia were collected in the month of March, 2015 at Kebbi State University of Science and Technology, Aliero (KSUSTA) main campus. The plant was identified taxonomically and authenticated at the Department of Biological Science, Kebbi State University of Science and Technology Aliero, Nigeria with a voucher specimen no 001.
Plant Extraction
The collected leaves of I. asarifolia were air-dried and then grounded into powder. 200 g of the powdered leave was macerated in 2000 mL of methanol: Water (70:30) for 72 hours, filtered using muslin cloth and dried in an oven at 45ºC.
The percentage yield of the hydromethanolic extract of I. asarifolia was 32.95%.
Animals
Albino rats were used for the study. They were purchased at the animal house of Usmanu Danfodio University Sokoto, Sokoto State. All the animals were kept in the cage and allow acclimatizing for one week in Biochemistry Laboratory of Kebbi State University of Science and Technology Aliero, Kebbi State, before the experiment started. The animals were fed with standard pellet diet and water. The container for the food and water were washed and cleaned daily as food and water were renewed every day to ensure hygiene and maximum comfort for the animal.
Phytochemical Screening
The presence of various phytochemical constituents in the extract was determined using the standard screening tests [12] .
Lethal Dose Determination (LD 50 )
The up and down procedure as described by Dixon [12] was used to evaluate the oral acute toxicity of hydromethanolic leaves extract of I. asarifolia. Five non-pregnant adult albino rats randomly selected from the pull of acclimatized rats were used for this experiment. The animals were weighed, marked and individually housed in cages prior to treatment. The rats to be treated were fasted overnight but allowed free access to water. Freshly prepared hydromethanolic leaves extract of I. asarifolia was administered orally at a limited dose of 3000 mg/kg. The first animal was dosed and observed for sign of toxicity such as hyperactivity, hypoactivity, spasm, ruffled fur, emesis, inappetance, scratching of mouth part, coma or death. If the animal survived, the same procedure was adopted until all the five rats were dosed and observed for 48 hours for signs of acute toxicity, morbidity and mortality for the first 48 hours and up to 14 days. The behavioral changes and other changes observed in animals were recorded according to Organization for Economic and Cultural Development (OECD) 425 guidelines [13] .
Antidiarrhoea Studies
Gastrointestinal motility test
Rats were fasted for 18 h and divided into five groups of five animals each. Group I received 5 mL/kg normal saline orally, group II received Loperimide (5 mg/kg), group III -V received hydromethanolic leave extract of Ipomea asarifolia (150, 300 and 600 mg/kg) respectively. After 1h of administration, 1mL of deactivated charcoal meal was administered to all the rats. Thirty minutes later, each rat was sacrificed and the small intestine removed. The total length of the intestine and the distance moved by the charcoal meal from the pylorus to the caecum was measured (cm). The intestinal charcoal transit was expressed as a percentage of the distance moved by charcoal to the length between pylorus and the caecum [14] and was calculated according to the following formula: % Inhibition of intestinal transit = {(distance travelled by charcoal meal in control grouptreated group) / Distance travelled by charcoal meal in control group × 100}
Castor oil induced diarrhea
Twenty rats were fasted for 18 h and divided into five groups of five animals each. Castor oil (1 mL) was orally given to all groups of animals for the induction of diarrhoea. Thirty minutes after castor oil administration various treatments were given. Group I (control) animals were treated with normal saline (5 mL/kg), Group II animals were treated with Loperamide (5 mg/kg), a positive control. Group III-V was treated with hydromethanolic extract of Ipomea asarifolia (150, 300 and 600 mg/kg) orally administered. Animals were placed separately in individual cages lined with filter paper. The filter papers were changed every hour and the severity of diarrhoea was assessed hourly for 6 hours [15] . The total score of diarrhoea faeces for the control group was considered as 100% and percentage inhibition of diarrhoea was calculated using the following formula: % Inhibition of diarrhoea = {(Total no. of diarrheal faeces in control group -Total no. of diarrheal faeces in treated group) /Total no. of diarrheal faeces in control group × 100}
Castor oil induced enteropooling
Intraluminal fluid accumulation was determined by the method described by Robert et al. [16] . Rats were divided into five groups of five animals each. One hour before oral administration of castor oil (2 mL/rat.), group I orally received normal saline (5 mg/kg) and served as control, group II animals received Loperamide (5 mg/kg) while groups III -V through oral intubation, respectively received the plant extract at 150, 300 and 600 mg/kg body weight respectively. Two hours later, the rats were sacrificed and the small intestine from the pylorus to the caecum was isolated. The intestinal contents were collected by milking into a graduated tube and their volume measured.
Statistical Analysis
The results were expressed in as mean standard error of mean (SEM) and statistical analysis were carried out employing one way analysis of variance (ANOVA) followed by Dunnett multiple comparisons test at p<0.05 significance level using Graphpad software, San Diego California USA, (www.graphpad.com).
RESULTS AND DISCUSSION
The percentage yield of Hydromethanolic leaves extract of Ipomea asarifolia (HLEIA) was found to be 32.95%. The high percentage yield of HLEIA suggests that the plant is a good source of extract since it contains sufficient amount which could be subjected further for isolation studies.
In the acute oral toxicity studies, it was observed that oral administration of HLEIA to the rats at 3000 mg/kg neither caused no mortality nor signs (hyperactivity, spasm, ruffled fur, emesis, inappetance etc.) of toxicity in the animals within the first 24 hours and up to 14 days after its administration. This indicates that the lethal median dose (LD 50 ) of the extract is greater than 3000 mg/kg suggesting the plant extract may be considered safe for consumption as herbal formulation [17] .
One hour after castor oil administration, all the rats in the control group produced copious diarrhoea. HLEIA produced a marked antidiarrhoea effect in the rats, as shown in Table 1 .
At 150 mg/kg, the extract significantly (p<0.01) decreased the total number of wet faeces produced upon administration of castor oil compared with control group. Highest inhibition percentage of defecation was observed with the extract at 150 mg/kg (40.00%) and with Loperamide (64.62%).
Several studies have shown that prior administration with some plant extract had protective effect on the intestinal tract. These studies have validated the use of antidiarrhoea medicinal plants by investigating the biological activity of extracts of such plants which have antispasmodic effects, delayed intestinal transit, reduced gut motility, stimulate water adsorption, or reduce the intraluminal fluid accumulation [18, 19, 20, 21] .
In antimotility test, sub-chronic administration of graded doses of HLEIA showed significant effect in treated animals receiving plant extract at 300 mg/kg (P<0.01) and at 600 mg/kg (P<0.05) respectively compared with the control (Table 2) . There was also a significant increase (P<0.01) in percentage intestinal transit in the drug-treated group when compared with the control. The highest anti-diarrhoea effect was produced at 300 mg/kg of the extract, which was comparable to the effect of the standard drug Loperamide.
Gastrointestinal motility test with activated charcoal was carried out to find the effect of the hydromethanolic extract of I. asarifolia on peristalsis movement. The result shows that HLEIA (300 mg/kg) was found to be comparable with the standard drug Loperamide, a drug which is widely used for the treatment of diarrhoea. Loperamide is known to exert its antidiarrhoea activity by changing the motor function of the intestine, which results in increased capacitance of the gut and a delay in the passage of fluid through the intestine [22] . Castor oil caused accumulation of water and electrolytes in intestinal loop. HLEIA compare with the control, significantly (P < 0.01) and dose dependently inhibited castor oil-induced enteropooling in rats ( Table 3 ). The inhibition rates for the extract were 24.02, 41.69 and 50.53 % respectively at 150, 300 and 600 mg/kg. The intestinal fluid in control animals was 2.83 ± 0.48 mL. Inhibitions of intestinal fluid accumulation were 24.02, 41.69 and 50.53% respectively at 150, 300 and 600 mg/kg. The standard drug Loperamide (5 mg/kg), also significantly inhibited intestinal fluid accumulation (60.07%).
Castor oil produces diarrhoea due to its most active metabolite, ricinoleic acid by hypersecretory response, which stimulates peristaltic activity in the small intestine, leading to changes in the electrolyte permeability of the intestinal mucosa [23] . Ricinoleic acid causes irritation and inflammation of the intestinal mucosa leading to the release of prostaglandins which stimulate hyper-motility, alteration in the electrolyte permeability of the intestinal mucosa and increase in the volume of intestinal contents by preventing the reabsorption of sodium, potassium and water [24, 25, 26] . In the present study, HLEIA showed a dose-related antienteropooling effect via reduced volume of the intestinal contents and also significantly inhibited castor oil-induced diarrhoea in rats by the significant reduction of the number of diarrhoeal episodes and total faeces. This implies that the extract probably enhanced the absorption of electrolytes and water from the intestinal lumen, while reducing the rate of their secretion into the small intestine or has the ability to inhibit the castor oil-induced intestinal accumulation of fluid in a manner similar to the standard antidiarrhoeal drug (Loperamide) [22] .
In the phytochemical analysis, HLEIA showed the presence of alkaloids, saponins, terpenoids, tannins, phenols, steroids and resins. The need for phytochemical screening has become imperative since many plants accumulate biologically active complex organic chemicals (secondary metabolites) in their tissues. Previous reports have demonstrated that antidiarrhoeal properties of medicinal plants were due to tannins, alkaloids, saponins, terpeniods, flavonoids and sterols [27, 28, 29, 30, 31] . It could therefore be suggested that the secondary metabolites present in I. asarifolia could be responsible for the pharmacological effects observed.
CONCLUSION
The present study reveals that hydromethanolic leaves extract of I. asarifolia contains phytocontistuents such as alkaloids, terpenoids, resins, tannin, saponin, phenols and steroids that are known for their antidiarrhoeal properties. The result obtained in this research establishes its efficacy and scientifically validate the use of I. asarifolia in the treatment of diarrhoea. Further research need to be undertaken to isolate and purify the bioactive components of this plant.
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